Elderly dialysis patients: analysis of factors affecting long-term survival in 4-year prospective observation

Int Urol Nephrol. 2012 Jun;44(3):955-61. doi: 10.1007/s11255-012-0166-4. Epub 2012 Apr 15.

Abstract

Purpose: To assess factors influencing the long-term survival of elderly dialysis patients.

Methods: The study group consisted of 51 prevalent dialysis patients aged over 70 years (32 F and 19 M, all caucasians), who had been on a chronic hemodialysis (27) or peritoneal dialysis program (24) for at least 2 months; median age was 77 years, median time on dialysis before inclusion was 16 months, and median residual diuresis was 600 ml. The patients were prospectively followed up to 4 years, and an analysis of factors affecting survival was performed.

Results: Thirteen patients from the initial cohort of 51 (25.5 %) survived the whole 48-month observation period: 10 HD patients (37 %) and 3 PD patients (12.5 %). Annual mortality rate was 28.2 %: 37.4 % on PD vs. 20.9 % on HD. The dialysis modality had a significant impact on patients' survival (p = 0.049; Cox F-test). The independent mortality risk factors in the Cox proportional hazard regression model were higher plasma pro-atrial natriuretic peptide (pro-ANP) (p = 0.006), lower residual diuresis (p = 0.048), and lower systolic blood pressure (BP) value (p = 0.039).

Conclusions: Paramount for the survival of the elderly on dialysis is adequate extracellular volume control. Residual renal function is a protective factor for the survival of elderly HD patients. This observation is novel, not previously reported in an elderly dialysis population.

MeSH terms

  • Aged
  • Atrial Natriuretic Factor / blood
  • Blood Pressure
  • Diuresis*
  • Female
  • Humans
  • Interleukin-1 / blood
  • Kidney / physiopathology
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / physiopathology
  • Kidney Failure, Chronic / therapy*
  • Longitudinal Studies
  • Male
  • Multivariate Analysis
  • Peritoneal Dialysis
  • Proportional Hazards Models
  • Prospective Studies
  • Renal Dialysis*

Substances

  • Interleukin-1
  • Atrial Natriuretic Factor